Immune Checkpoint Inhibitors in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review.

Cancers (Basel) · 2025 · PMC12523286 · PMID 41097798

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

For example, the interim results of ADMEC-O showed a 9–10% improvement in 1–2-year DFS with adjuvant nivolumab, but this did not reach statistical significance and OS outcomes remain not yet mature [ 18 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.